廣告
香港股市 將在 2 小時 47 分鐘 開市
  • 恒指

    17,763.03
    +16.12 (+0.09%)
     
  • 國指

    6,273.75
    -9.11 (-0.14%)
     
  • 上證綜指

    3,104.82
    -8.22 (-0.26%)
     
  • 道指

    37,903.29
    +87.37 (+0.23%)
     
  • 標普 500

    5,018.39
    -17.30 (-0.34%)
     
  • 納指

    15,605.48
    -52.34 (-0.33%)
     
  • Vix指數

    15.39
    -0.26 (-1.66%)
     
  • 富時100

    8,121.24
    -22.89 (-0.28%)
     
  • 紐約期油

    79.06
    +0.06 (+0.08%)
     
  • 金價

    2,331.10
    +20.10 (+0.87%)
     
  • 美元

    7.8221
    -0.0018 (-0.02%)
     
  • 人民幣

    0.9249
    -0.0003 (-0.03%)
     
  • 日圓

    0.0501
    +0.0008 (+1.60%)
     
  • 歐元

    8.3824
    +0.0374 (+0.45%)
     
  • Bitcoin

    57,985.95
    -2,662.06 (-4.39%)
     
  • CMC Crypto 200

    1,271.66
    -67.40 (-5.04%)
     

CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors

April 4 (Reuters) - CVS Caremark, the pharmacy benefit management subsidiary of CVS Health Corp, will add Perrigo's birth control pill to its preventive services oral contraceptives list and make it available at no cost for many plan sponsors, according to a pharmacy update on March 28.

The U.S. FDA in July approved over-the-counter use of Perrigo's drug Opill, making it the first oral contraceptive in the country which can be purchased without prescription.

Opill was first approved for prescription use in 1973.

Last month, Perrigo said Opill would be available at major retailers for a price of $19.99 and $49.99 for a one-month and three-month supply, respectively.

On Thursday, drugstore chain operator Rite Aid said Opill would be available at its pharmacies in all locations. (Reporting by Christy Santhosh and Aishwarya Jain in Bengaluru; Editing by Vijay Kishore)